COM:AFTPHARM
AFT Pharmaceuticals
- Stock
Last Close
2.65
22/11 00:15
Market Cap
309.35M
Beta: -
Volume Today
57.96K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|
revenue | 69.05M - | 79.88M 15.69% | 84.87M 6.25% | 105.24M 24.00% | 112.86M 7.24% | 129.83M 15.04% | 155.82M 20.01% | 195.41M 25.41% | ||
cost of revenue | 43.21M - | 45.88M 6.19% | 44.40M 3.23% | 57.33M 29.13% | 64.36M 12.27% | 68.54M 6.49% | 83.66M 22.06% | 107.14M 28.07% | ||
gross profit | 25.84M - | 34.00M 31.59% | 40.48M 19.04% | 47.91M 18.37% | 48.50M 1.23% | 61.30M 26.39% | 72.16M 17.73% | 88.27M 22.32% | ||
selling and marketing expenses | 25.96M - | 28.53M 9.89% | 26.54M 6.98% | 26.20M 1.27% | 27.44M 4.71% | 28.33M 3.25% | 36.54M 28.99% | 45.26M 23.84% | ||
general and administrative expenses | 5.85M - | 8.31M 41.99% | 7.20M 13.31% | 9.11M 26.51% | 7.78M 14.56% | 7.77M 0.13% | 11.12M 43.08% | 11.21M 0.83% | ||
selling general and administrative expenses | 31.82M - | 36.84M 15.80% | 33.74M 8.41% | 35.31M 4.66% | 35.22M 0.26% | 36.10M 2.50% | 47.67M 32.02% | 56.47M 18.47% | ||
research and development expenses | 11.23M - | 8.23M 26.69% | 2.59M 68.55% | 1.98M 23.34% | 3.44M 73.24% | 5.51M 60.23% | 5.65M 2.56% | 8.09M 43.31% | ||
other expenses | 2.07M - | 2.82M 36.25% | 2.42M 13.95% | 2.49M 2.81% | 10.68M 328.37% | 1.49M 86.08% | 1.43M 3.63% | -189K 113.20% | 3.31M 1,850.79% | |
cost and expenses | 86.58M - | 91.29M 5.45% | 81.05M 11.22% | 95.41M 17.72% | 104.13M 9.14% | 110.15M 5.78% | 138.70M 25.92% | 171.70M 23.80% | ||
operating expenses | 33.47M - | 43.37M 29.57% | 45.41M 4.71% | 36.65M 19.29% | 38.08M 3.90% | 39.76M 4.42% | 41.61M 4.65% | 55.04M 32.27% | 64.56M 17.31% | |
interest expense | 3.88M - | 2.65M 31.61% | 8.42M 217.38% | 8.05M 4.34% | 3.44M 57.27% | 2.44M 29.24% | 2.87M 17.99% | 3.69M 28.30% | ||
ebitda | -14.13M - | -9.67M 31.52% | 6.48M 166.95% | 21.71M 235.19% | 12.43M 42.74% | 21.12M 69.88% | 20.40M 3.43% | 25.72M 26.10% | ||
operating income | -14.45M - | -10.01M 30.71% | 6.16M 161.49% | 20.93M 239.87% | 11.33M 45.87% | 20.08M 77.22% | 18.67M 6.99% | 23.71M 26.97% | ||
depreciation and amortization | 268K - | 326K 21.64% | 340K 4.29% | 319K 6.18% | 781K 144.83% | 1.10M 41.36% | 1.04M 5.43% | 1.72M 65.13% | 2.01M 16.76% | |
total other income expenses net | 2.40M - | 930K 61.30% | 1.97M 111.94% | 10.60M 437.54% | 1.49M 85.97% | 1.43M 3.63% | -189K 113.20% | -1.69M 793.12% | ||
income before tax | -18.33M - | -12.67M 30.90% | -2.26M 82.16% | 12.88M 670.03% | 7.89M 38.75% | 18.68M 136.91% | 15.80M 15.45% | 22.02M 39.37% | ||
income tax expense | 58K - | 58K 0% | 168K 189.66% | 185K 10.12% | 105K 43.24% | -1.16M 1,207.62% | 5.14M 542.39% | 6.41M 24.59% | ||
net income | -11.95M - | -18.39M 53.85% | -12.72M 30.80% | -2.43M 80.93% | 12.69M 622.95% | 7.78M 38.69% | 19.85M 155.05% | 10.65M 46.32% | 15.61M 46.51% | |
weighted average shs out | 27.57M - | 96.84M 251.20% | 97.25M 0.42% | 97.31M 0.06% | 97.31M 0.00% | 103.30M 6.15% | 104.68M 1.34% | 104.85M 0.16% | 104.87M 0.02% | |
weighted average shs out dil | 27.58M - | 97.11M 252.16% | 97.25M 0.14% | 97.31M 0.06% | 97.31M 0.00% | 103.30M 6.15% | 104.68M 1.34% | 104.85M 0.16% | 104.87M 0.02% | |
eps | -0.43 - | -0.19 55.81% | -0.13 31.58% | -0.02 80.85% | 0.12 581.93% | 0.08 37.25% | 0.19 152.32% | 0.10 47.37% | 0.15 50.00% | |
epsdiluted | -0.43 - | -0.19 55.81% | -0.13 31.58% | -0.02 80.85% | 0.12 581.93% | 0.08 37.25% | 0.19 152.32% | 0.10 47.37% | 0.15 50.00% |
All numbers in (except ratios and percentages)